Aug 26, 2021 02:27 PM IST
Under the terms of the definitive agreement, Jemincare will be responsible for exclusive development and commercialisation of the Nafithromycin in the select markets, Wockhardt said added.
- Aug 26, 2021 10:11 AM IST
Wockhardt will partner with Jemincare for the development and commercialisation of the Nafithromycin in China, Hong Kong, Macau and Taiwan
- Aug 13, 2021 12:34 PM IST
The Mumbai-based firm has entered into an agreement with Enso and Human Vaccine LLC , a wholly owned unit of the management company of RDIF to manufacture and supply Sputnik V, Sputnik Light vaccine against COVID-19, Wockhardt said in a regulatory filing.
- Aug 13, 2021 12:06 PM IST
The company will manufacture and supply up to 620 million doses of the Sputnik V and the Sputnik Light vaccines
- Jul 26, 2021 09:22 AM IST
- Jul 22, 2021 06:13 PM IST
- Jul 22, 2021 06:06 PM IST
- Jul 22, 2021 04:11 PM IST
The company had posted a net profit of Rs 759.75 crore for the corresponding period of the previous fiscal, Wockhardt said in a filing to BSE stock exchange.
- May 28, 2021 09:44 AM IST
- May 28, 2021 09:33 AM IST
- May 27, 2021 03:56 PM IST
Wockhardt reported a consolidated net loss of Rs 92.8 crore in the March 2021 quarter against a profit of Rs 48.3 crore in the year-ago quarter, dented by the weak US and India businesses.
- May 26, 2021 09:39 AM IST
A formal submission was made earlier in May and the Centre is “examining the offer”.
- Apr 08, 2021 04:38 PM IST
Wockhardt is among the nine private vaccination centres that were added by the Mira Bhayandar Municipal Corporation to intensify the inoculation drive in the twin city.
- Feb 02, 2021 09:22 AM IST
- Jan 20, 2021 01:37 PM IST
It cannot be ascertained if this was the first time when Jhunjhunwala bought a stake in the company or he held any shares of Wockhardt earlier also as companies are not required to publish names of shareholders if their individual holdings are below 1 percent.
- Dec 11, 2020 08:32 AM IST
Vaccine rollout will throw up opportunities not just for the domestic pharmaceutical and healthcare industry but also the logistics value chain, right from vaccine production, delivery, storage and then the actual immunisation
- Nov 03, 2020 09:22 AM IST
- Nov 03, 2020 09:11 AM IST
- Nov 02, 2020 07:46 PM IST
The company had posted a net loss of Rs 94.24 crore for the same period previous fiscal, Wockhardt said in a BSE filing.
- Oct 29, 2020 03:52 PM IST
Dr Reddy's US growth prospects have improved after its recent settlement with Bristol Myers Squibb to launch an oncology drug
- Aug 29, 2020 05:00 PM IST
The company had posted a net loss of Rs 36.88 crore for April-June 2019-20, Wockhardt said in a filing to BSE.
- Aug 04, 2020 09:47 AM IST
The agreement is for 30 million doses, which can be expanded to 400 million doses in the UK.
- Aug 03, 2020 06:00 PM IST
The manufacturing will be undertaken at CP Pharmaceuticals, a subsidiary of the company based in North Wales, Wockhardt said in a statement.
- Aug 03, 2020 03:44 PM IST
The company will fill-finish COVID-19 vaccines at CP Pharmaceuticals, a subsidiary of Wockhardt in Wrexham, North Wales.
- Jul 30, 2020 09:19 AM IST
Key drag for the Dr Reddy's is India business. Compared to its peers, it has a low revenue share in India and that too is majorly in the acute category